---
title: "BRC Group Holdings Secures Board Representation at Biomerica with 10.03% Stake"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297371163.md"
description: "BRC Group Holdings acquired a 10.03% stake in Biomerica via B. Riley Principal Capital, securing board representation and exclusive financial advisor status for 24 months. Filed on Aug 28, 2026, the investment allows BRC to influence strategy, propose operational changes, and potentially pursue a controlling interest."
datetime: "2026-08-28T21:26:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297371163.md)
  - [en](https://longbridge.com/en/news/297371163.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297371163.md)
generator: "portal-rs"
---

# BRC Group Holdings Secures Board Representation at Biomerica with 10.03% Stake

BRC Group Holdings, Inc. disclosed a 10.03% stake in Biomerica, Inc. through its affiliate B. Riley Principal Capital, LLC. The Schedule 13D was filed on Aug. 28, 2026, following purchases completed around Aug. 20, 2026. The deal grants B. Riley a board representative and positions the firm to influence strategy.

**Investor Intent**

B. Riley Principal Capital acquired the shares for investment and gained the right to name a director at Biomerica. The firm also secured registration rights for the shares and signed a 24‑month engagement under which "BRS will serve as the Issuer's exclusive financial advisor in connection with the evaluation and potential pursuit of certain strategic transactions."

The group plans to monitor Biomerica closely and may press for changes if it sees opportunity, including "proposing changes in the Issuer's operations, governance or capitalization." It also left open the option of deals that could increase its influence, including "pursuing a transaction that would result in the Reporting Persons' acquisition of all or a controlling interest in the Issuer."

**Investor's Background**

BRC Group Holdings, Inc. is a Delaware-based holding company that oversees investment activities across the B. Riley platform, including B. Riley Principal Capital, LLC. Through affiliates like B. Riley Securities, the firm often pairs equity investments with advisory roles to drive strategic actions at small and mid-cap companies. Bryant R. Riley, the company’s Co-Chief Executive Officer and Chairman, is known for event-driven investments and hands-on involvement in portfolio companies.

Original SEC Filing: BIOMERICA INC \[ BMRA \] - SCHEDULE 13D - Aug. 28, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BMRA.US](https://longbridge.com/en/quote/BMRA.US.md)
- [RILYT.US](https://longbridge.com/en/quote/RILYT.US.md)
- [RILYP.US](https://longbridge.com/en/quote/RILYP.US.md)
- [RILY.US](https://longbridge.com/en/quote/RILY.US.md)
- [RILYL.US](https://longbridge.com/en/quote/RILYL.US.md)
- [RILYG.US](https://longbridge.com/en/quote/RILYG.US.md)
- [RILYN.US](https://longbridge.com/en/quote/RILYN.US.md)
- [RILYK.US](https://longbridge.com/en/quote/RILYK.US.md)
- [RILYZ.US](https://longbridge.com/en/quote/RILYZ.US.md)

## Related News & Research

- [Biomerica Enters Securities Purchase Agreement for Private Placement With Investors](https://longbridge.com/en/news/297088565.md)
- [Biomerica FY26 net sales drop 16% to $4.45 million; dividend, interest and other income more than doubled to $1.23 million](https://longbridge.com/en/news/297561919.md)
- [Biomerica prices 1,393,705-share private placement at $1.6 per share, raising $2.23 million](https://longbridge.com/en/news/297087942.md)
- [Biomerica CEO Zackary S. Irani reports acquisition of $50,000 common shares](https://longbridge.com/en/news/297235006.md)
- [BRC Group amends Co-CEO Bryant Riley employment deal, extends incentive pay through fiscal 2027](https://longbridge.com/en/news/297365149.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**